Literature DB >> 17084741

XDR tuberculosis: an indicator of public-health negligence.

Annelies Van Rie1, Donald Enarson.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17084741     DOI： 10.1016/S0140-6736(06)69575-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Girum Shiferaw; Yimtubezinash Woldeamanuel; Mekdes Gebeyehu; Feven Girmachew; Daniel Demessie; Eshetu Lemma
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

2.  Critical evaluation of the Global DOTS Expansion Plan.

Authors:  Donald A Enarson; Nils E Billo
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

3.  Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Yu Pang; Hui Xia; Zhiying Zhang; Junchen Li; Yi Dong; Qiang Li; Xichao Ou; Yuanyuan Song; Yufeng Wang; Richard O'Brien; Kai Man Kam; Junying Chi; Shitong Huan; Daniel P Chin; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2013-03-20       Impact factor: 5.948

4.  Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.

Authors:  Gabriel M Cohen; Paul K Drain; Farzad Noubary; Christie Cloete; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

Review 5.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

6.  Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC).

Authors:  Sharmila Sivendran; Victoria Jones; Dianqing Sun; Yi Wang; Anna E Grzegorzewicz; Michael S Scherman; Andrew D Napper; J Andrew McCammon; Richard E Lee; Scott L Diamond; Michael McNeil
Journal:  Bioorg Med Chem       Date:  2009-11-20       Impact factor: 3.641

7.  Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.

Authors:  Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

8.  Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.

Authors:  Wenli Zhang; Victoria C Jones; Michael S Scherman; Sebabrata Mahapatra; Dean Crick; Suresh Bhamidi; Yi Xin; Michael R McNeil; Yufang Ma
Journal:  Int J Biochem Cell Biol       Date:  2008-05-15       Impact factor: 5.085

Review 9.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis.

Authors:  Farahnaz Movahedzadeh; Paul R Wheeler; Premkumar Dinadayala; Yossef Av-Gay; Tanya Parish; Mamadou Daffé; Neil G Stoker
Journal:  BMC Microbiol       Date:  2010-02-18       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.